-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Chinook Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2022.
- Chinook Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$66.9M, a 77.8% decline year-over-year.
- Chinook Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$246M, a 166% decline year-over-year.
- Chinook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$188M, a 82.5% decline from 2021.
- Chinook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$103M, a 26.1% decline from 2020.
- Chinook Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$81.6M, a 75.5% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)